trial · primary record
Neridronate
Complex Regional Pain Syndrome Type I
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 270 |
| Primary completion | 2028-01 |
| Primary endpoint | Change in pain intensity from baseline to Week 12. |
| Registry ID | NCT07210515 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:34:28.250Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07210515
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.